Section 10400.1 - Beta-Cyanogenetic Glucosides ( "Laetriles") Agent for Treatment of Cancer(a) The Department of Public Health has carefully considered a document entitled "A Report on the Treatment of Cancer with Beta-Cyanogenetic Glucosides ('Laetriles')" dated May 20, 1963, and is satisfied beyond a reasonable doubt that the findings therein are true. The Department hereby ratifies and adopts said report as its own and a copy of same is on file with the California State Department of Public Health and is available for public inspection at its office located at 2151 Berkeley Way, Berkeley, California.(b) The Department of Public Health hereby finds that beta-cyanogenetic glucosides including amygdalin (with or without the addition of diisopropyl ammonium iodide), and prunasin, commonly known as "Laetriles," are of no value in the diagnosis, treatment, alleviation or cure of cancer and that the use of one or more of these agents in early cancer to the exclusion of conventional treatment might well be dangerous since treatment with acceptable, modern, curative methods (surgery or radiation) would thereby be delayed potentially until such time as metastases had occurred and the cancer therefore might no longer be curable. In late disease palliative effect is lacking. The Department recommends that the public refrain from using any of the said agents or any agent, drug, medicine, compound or device substantially similar thereto in the diagnosis, alleviation, treatment or cure of cancer.(c) Except as otherwise provided in Section 1708 of the California Health and Safety Code the prescription, administration, sale or other distribution of beta-cyanogenetic glucosides including amygdalin (with or without the addition of diisopropyl ammonium iodide) and prunasin, commonly known as "Laetriles" or, any substantially similar agent, drug, medicine, compound or device to any patient who has or who believes that he has or may have cancer is prohibited; and the Department shall upon learning of such prescription, administration, sale or other distribution take appropriate steps to cause such persons so doing to cease and desist therefrom.(d) No person shall for the purpose of prescribing, administering, selling or otherwise distributing beta-cyanogenetic glucosides including amygdalin (with or without the addition of diisopropyl ammonium iodide) or prunasin, commonly known as "Laetriles," make any representation that said agents have any value in arresting, alleviating or curing cancer; and the Department shall upon learning of such representation take appropriate steps to cause such person to cease and desist from such representation and shall take such other and further steps as may be appropriate to cause such representation to be discontinued.Cal. Code Regs. Tit. 17, § 10400.1
1. New section filed 10-3-63; effective thirtieth day thereafter (Register 63, No. 17). Note: Authority cited: Sections 102 and 208, Health and Safety Code. Reference: Section 1704, Health and Safety Code.
1. New section filed 10-3-63; effective thirtieth day thereafter (Register 63, No. 17).